RadNet Inc (RDNT): Rasio kapitalisasi marang pendapatan

Tandha merek RadNet Inc (RDNT)

The P/S multiple reflects the valuation dynamics of RadNet, Inc. (RDNT), whose success is driven by the shift of patients from hospitals to the private sector. Aggressive expansion and the implementation of AI analytics are designed to increase service profitability. The value of 2.50 reflects this status, considering the business's dependence on insurance payouts, equipment costs, and the availability of specialized physicians.

RDNT Kapitalisasi marang pendapatan RadNet Management (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan RadNet Corp (RDNT)

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:radnet.com (RDNT)
Produk dadi RadNet, Inc.

Investors must determine whether the current valuation of RadNet, Inc. (RDNT) results from market undervaluation or signals a decline in business efficiency. The revenue multiple trend reflects the proportion between market capitalization and sales volume, where a declining ratio—coupled with continued optimization of diagnostic equipment logistics and reliable consumable supplies—confirms the asset's fundamental resilience and attractiveness.

Perusahaan pesaing

hcahealthcare.com - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Tenet Healthcare Corporation THC|FMS: Rasio kapitalisasi marang pendapatan|Solventum Inc. - Multiplikator P/S|Rega marang dodolan Encompass|UHS (uhsinc.com) - Kapitalisasi marang pendapatan|DVA: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan OPCH|SGRY: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PINC|Koefisien rega marang pendapatan America's Best Contacts & Eyeglasses|Rasio rega marang pendapatan Progyny, Inc. PGNY|ARDT: Rasio kapitalisasi marang pendapatan|Select Medical Holdings - Multiplikator P/S|Astrana Health Inc (ASTH) - Kapitalisasi marang pendapatan|MD (Pediatrix Medical Group, Inc.) - Kapitalisasi marang pendapatan|USPH - Koefisien rega marang pendapatan|Rasio rega marang pendapatan The Pennant Group, Inc.|ORGO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NUTX|Auna S.A. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan SBC Medical Group Holdings Inc. SBC|EOLS: Rasio kapitalisasi marang pendapatan|CYH: Kapitalisasi marang pendapatan|The Beauty Health - Kapitalisasi marang volume dodolan|MDWD (mediwound.com) - Kapitalisasi marang pendapatan|BTMD: Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan The Joint Corporation|DCGO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PIII|GANX - Rega marang dodolan|Multiplikator P/S EUDA (EUDA Health Holdings Limited)|Multiplikator P/S Basel Medical BMGL|CLGN: Kapitalisasi marang pendapatan|Cuprina Holdings Limited - Kapitalisasi marang volume dodolan|Concord Medical Services (CCM) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ashs.com|MRM (MEDIROM Healthcare Group) - Multiplikator P/S|Rega marang dodolan Avalon GloboCare Corporation ALBT|Rasio rega marang pendapatan DIH Holding US Inc. (DHAI)|Carmell Corp - Rasio kapitalisasi marang pendapatan|NewGenIvf Group Limited - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ATIP (ATI Physical Therapy Inc.)|CMAX - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KDLY (Kindly MD Inc)|MODV: Multiplikator P/S|Novo Integrated Sciences Corp (NVOS) - Multiplikator P/S|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan BACK (imacholdings.comm)